Drug discovery and development in TB

Fighting the global tuberculosis (TB) epidemic calls for the development of new, more potent antibiotics that inhibit Mycobacterium tuberculosis' critical proteins. The main goal of drug design and discovery is to identify a chemical that can specifically target a specific cavity in a protein and prevent it from engaging in its enzymatic function. A variety of studies, including clinical trials, are subsequently performed on the substance in question to determine how well it works to combat the infection inside the host. Recently, as opposed to the tedious and time-consuming old methods of drug design, new strategies that involve computational and analytical methodologies have improved the odds of drug discovery.
A new generation of software that is utilized to create and optimize active compounds that can be used in chemotherapeutic research in the future to tackle global tuberculosis resistance has improved computational methodologies in drug creation.


    Related Conference of Drug discovery and development in TB

    October 04-04, 2023

    6th International Conference on Rare Diseases

    Amsterdam, Netherlands
    October 09-10, 2023

    15th Euro-Global Conference on Infectious Diseases

    Zurich, Switzerland
    October 25-26, 2023

    13th International Conference on GI Disorders

    Nova Scotia, Canada
    December 07-08, 2023

    6th Pathology and Infectious Disease Conference

    Prague, Czech Republic
    February 22-23, 2024

    11th International Congress on Infectious Diseases

    Barcelona, Spain
    February 22-23, 2024

    9th Annual Summit on Rare Diseases and Orphan Drugs

    Zurich, Switzerland

    Drug discovery and development in TB Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in